Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies

References

• Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol. 2007;25:3274–3280.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis off Publ Infect Dis Soc Am. 2005;40:S240–S245.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Mokart D, Pène F, et al. Outcomes of critically Ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study. J Clin Oncol. 2013;47:2365.
   Google Scholar
• Azoulay E, Darmon M, Delclaux C, et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med. 2002;30:781–786.
   PubMed Web of Science ®Google Scholar
• Karlin L, Darmon M, Thiéry G, et al. Respiratory status deterioration during G-CSF-induced neutropenia recovery. Bone Marrow Transplant. 2005;36:245–250.
   PubMed Web of Science ®Google Scholar
• Clark OAC, Lyman GH, Castro AA, et al. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials. JCO. 2005;23:4198–4214.
   PubMed Web of Science ®Google Scholar
• Lee S, Knox A, Zeng ISL, et al. Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis. Support Care Cancer. 2013;21:841–846.
   PubMed Web of Science ®Google Scholar
• Ohno R, Tomonaga M, Kobayashi T, et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med. 1990;323:871–877.
   PubMed Web of Science ®Google Scholar
• Ottmann OG, Hoelzer D, Gracien E, et al. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood. 1995;86:444–450.
   PubMed Web of Science ®Google Scholar
• Gerhartz HH, Engelhard M, Meusers P, et al. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin’s lymphomas. Blood. 1993;82:2329–2339.
   PubMed Web of Science ®Google Scholar
• Cardinal-Fernández P, Bajwa EK, Dominguez-Calvo A, et al. The presence of diffuse alveolar damage on open lung biopsy is associated with mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Chest. 2016;149:1155–1164.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Herigault S, Levame M, et al. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. Crit Care Med. 2003;31:1442–1448.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Attalah H, Yang K, et al. Exacerbation by granulocyte colony-stimulating factor of prior acute lung injury: implication of neutrophils. Crit Care Med. 2002;30:2115–2122.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Attalah H, Harf A, et al. Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data. Chest. 2001;120:1695–1701.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–710.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Baker CS, Evans TW, et al. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J. 2000;15:895–901.
   PubMed Web of Science ®Google Scholar
• Mokart D, Guery BP, Bouabdallah R, et al. Deactivation of alveolar macrophages in septic neutropenic ARDS. Chest. 2003;124:644–652.
   PubMed Web of Science ®Google Scholar
• Mokart D, Kipnis E, Guerre-Berthelot P, et al. Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor. Crit Care. 2008;12:R17.
   PubMed Web of Science ®Google Scholar
• Escudero Vilaplana B, Ruiz Gutiérrez J, Cantos Sánchez de Ibarguen B, et al. Critically Ill patient due to pneumonitis secondary to the use of filgrastim. Am J Ther. 2016;23:e1946.
   PubMed Web of Science ®Google Scholar
• Ibayashi Y, Ohyama H, Hashimoto Y, et al. A case report of interstitial pneumonia caused by granulocyte colony-stimulating factor. No Shinkei Geka. 1994;22:169–174.
   PubMedGoogle Scholar
• Arimura K, Inoue H, Kukita T, et al. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica. 2005;90:ECR10.
   PubMedGoogle Scholar
• Hermesh T, Moran TM, Jain D, et al. Granulocyte colony-stimulating factor protects mice during respiratory virus infections. PLoS One. 2012;7:e37334.
   PubMed Web of Science ®Google Scholar
• Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994;84:1737–1746.
   PubMed Web of Science ®Google Scholar
• Basu S, Hodgson G, Zhang HH, et al. “Emergency” granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood. 2000;95:3725–3733.
   PubMed Web of Science ®Google Scholar
• Wiedermann FJ, Mayr AJ, Hobisch-Hagen P, et al. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res. 2003;23:729–736.
   PubMed Web of Science ®Google Scholar
• Paine R, Standiford TJ, Dechert RE, et al. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med. 2012;40:90–97.
   PubMed Web of Science ®Google Scholar
• Pettilä V, Takkunen O, Varpula T, et al. Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study. Crit Care Med. 2000;28:3620–3625.
   PubMed Web of Science ®Google Scholar
• Balsat M, Xhaard A, Lengline E, et al. Worsening of respiratory status during neutropenia recovery in noncritically ill hematological patients: results of a prospective multicenter study. Respir Int Rev Thorac Dis. 2015;90:229–234.
   Google Scholar
• Sasse EC, Sasse AD, Brandalise S, et al. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. Cochrane Database Syst Rev 2005;20:CD004139.
   Google Scholar
• Usuki K, Urabe A, Masaoka T, et al. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study. Br J Haematol. 2002;116:103–112.
   PubMed Web of Science ®Google Scholar
• Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991;325:164–170.
   PubMed Web of Science ®Google Scholar
• Trillet-Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer. 1993;29:319–324.
   Web of Science ®Google Scholar
• Gruson D, Hilbert G, Vargas F, et al. Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients. Crit Care Med. 2000;28:3155–3160.
   PubMed Web of Science ®Google Scholar
• Bouchama A, Khan B, Djazmati W, et al. Hematopoietic colony-stimulating factors for neutropenic patients in the ICU. Intensive Care Med. 1999;25:1003–1005.
   PubMed Web of Science ®Google Scholar